Oric Pharmaceuticals, Inc.
ORIC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796280
In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.
Q1 2026 vs. Q4 2025
How the institutions holding Oric Pharmaceuticals, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 165 | 1 | 182 | +18 |
| Shares | 119.7M | 4.54M | 119.4M | +4.25M (+3.7%) |
| Value | $979.6M | $37.2M | $1.51B | +$567.4M (+60.2%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (40)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
Sold out (22)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Point72 Asset Management, L.P. | 2,923,077 | $23.9M |
| Renaissance Technologies LLC | 572,724 | $4.68M |
| Kalehua Capital Management LLC | 267,059 | $2.18M |
| Squarepoint Ops LLC | 229,383 | $1.88M |
| Quest Partners LLC | 44,387 | $363.1K |
| VARCOV Co. | 32,036 | $262.1K |
| NEOS Investment Management LLC | 28,269 | $231.2K |
| Susquehanna Fundamental Investments, LLC | 25,518 | $208.7K |
| Freestone Grove Partners LP | 24,207 | $198.0K |
| Entropy Technologies, LP | 22,799 | $186.5K |
| Oxford Asset Management LLP | 19,638 | $160.6K |
| DRW Securities, LLC | 19,194 | $157.0K |
| Schonfeld Strategic Advisors LLC | 14,349 | $117.4K |
| CI Private Wealth, LLC | 12,512 | $102.3K |
| Scientech Research LLC | 11,533 | $94.3K |
| Axq Capital, LP | 10,366 | $84.8K |
| Engineers Gate Manager LP | 10,335 | $84.5K |
| Bellevue Group AG | 9,706 | $79.4K |
| Royal Bank of Canada | 2,344 | $18.0K |
| Amalgamated Bank | 2,078 | $17.0K |
| CWM Advisors, LLC | 753 | $6.16K |
| Daiwa Securities Group Inc. | 249 | $2.00K |
Not filed for Q1 2026 yet (1)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 4,541,974 | $37.2M |